Latest filings (excl ownership)
CT ORDER
Confidential treatment order
15 Mar 17
15-12B
Securities registration termination
7 Mar 17
8-K/A
Financial Statements and Exhibits
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
25-NSE
Exchange delisting
24 Feb 17
8-K
Completion of Acquisition or Disposition of Assets
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Feb 17
SC 14D9/A
Tender offer solicitation (amended)
23 Feb 17
SC TO-T/A
Third party tender offer statement (amended)
23 Feb 17
SC 14D9/A
Tender offer solicitation (amended)
10 Feb 17
SC TO-T/A
Third party tender offer statement (amended)
10 Feb 17
SC 14D9/A
Tender offer solicitation (amended)
6 Feb 17
SC TO-T/A
Third party tender offer statement (amended)
6 Feb 17
8-K
Departure of Directors or Certain Officers
25 Jan 17
SC 14D9
Tender offer solicitation
25 Jan 17
SC TO-T
Third party tender offer statement
25 Jan 17
8-K
Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner
17 Jan 17
8-K
Entry into a Material Definitive Agreement
17 Jan 17
SC14D9C
Written communication relating to third party tender offer
17 Jan 17
SC14D9C
Written communication relating to third party tender offer
13 Jan 17
SC TO-C
Information about tender offer
12 Jan 17
SC14D9C
Written communication relating to third party tender offer
12 Jan 17
SC 14D9
Tender offer solicitation
11 Jan 17
SC TO-C
Information about tender offer
11 Jan 17
10-Q
2016 Q3
Quarterly report
9 Nov 16
Latest ownership filings
SC 13G/A
Derma Sciences, Inc.
2 Feb 18
SC 13G/A
Derma Sciences, Inc.
10 Mar 17
SC 13D/A
Derma Sciences, Inc.
28 Feb 17
4
SAMUEL E NAVARRO
24 Feb 17
4
STEPHEN T WILLS
24 Feb 17
4
JOHN E YETTER
24 Feb 17
4
SRINI CONJEEVARAM
24 Feb 17
4
Frederic Eigner
24 Feb 17
4
Brett Hewlett
24 Feb 17
4
ROBERT C COLE
24 Feb 17
4
ROBERT G MOUSSA
24 Feb 17
4
JOHN E YETTER
16 Feb 17
4
ROBERT C COLE
16 Feb 17
4
ROBERT G MOUSSA
16 Feb 17
4
Frederic Eigner
16 Feb 17
4
SRINI CONJEEVARAM
16 Feb 17
4
STEPHEN T WILLS
16 Feb 17
SC 13G/A
Derma Sciences, Inc.
14 Feb 17
SC 13G/A
Derma Sciences, Inc.
8 Feb 17
SC 13G/A
Derma Sciences, Inc.
2 Feb 17
SC 13G/A
Derma Sciences, Inc.
24 Jan 17
SC 13D
Derma Sciences, Inc.
23 Jan 17
SC 13D/A
Derma Sciences, Inc.
13 Jan 17
4
Barry Wolfenson
2 Aug 16
4
SRINI CONJEEVARAM
3 Jun 16
4
ROBERT G MOUSSA
3 Jun 16
4
STEPHEN T WILLS
3 Jun 16
4
Brett Hewlett
3 Jun 16
4
SAMUEL E NAVARRO
3 Jun 16
4
BRUCE F WESSON
2 Jun 16
4
AMY S PAUL
2 Jun 16
4
Brett Hewlett
7 Apr 16
4
Barry Wolfenson
4 Mar 16
4
ROBERT C COLE
4 Mar 16
4
Frederic Eigner
4 Mar 16
4
JOHN E YETTER
4 Mar 16
SC 13G/A
Beneficial ownership report (amended)
16 Feb 16
SC 13G/A
Derma Sciences, Inc.
16 Feb 16
SC 13G/A
Derma Sciences, Inc.
11 Feb 16
SC 13G/A
Derma Sciences, Inc.
10 Feb 16